Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-15 · accession 0001567619-23-005285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | A - Grant | $0.00 | +36.1K | 524.0K | +7% | $0 |
| DM | 2023-03-17 | 2023-03-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | F - Tax | $92.86 | -98.1K | 514.5K | -16% | -$9.11M |
| D | 2023-03-17 | 2023-03-15 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | A - Grant | $0.00 | +49.4K | 49.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | A | A | 36,100 | $0.00 | 523,956 | D | — | — | (F1) Restricted stock units granted on March 15, 2023. Price not applicable. |
| 2 | Common | Common Stock | 2023-03-16 | F | D | 88,623 | $93.41 | 425,896 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-15 | F | D | 9,437 | $87.74 | 514,519 | D | — | — | |
| 4 | Derivative | Stock Option (Right to buy Common Stock) | 2023-03-15 | A | A | 49,430 | $0.00 | 49,430 | D | $87.74 · 2024-03-15 to 2033-03-14 | 49,430 Common Stock | (F2) Option grant vests 12/36th on March 15, 2024 and 1/36th on the 15th day of each month thereafter. |